PharmaBoardroom

5 Denmark Pharma Country Managers Talk Market Access

Long established as a premier early launch country for innovative medicines within Europe, the Danish market access system has become more complicated…

Tore von Würden – Country Director Denmark & Iceland,…

Tore von Würden talks through Amgen Denmark’s focus areas of osteoporosis, cardiovascular disease, haematology, and oncology, where it hopes not…

Tashia Lentz – Managing Director, Biogen Denmark

Tashia Lentz of Biogen outlines what she sees as an increasingly tough market access environment for new treatments in Denmark and calls for greater…

China News Roundup: Sinopharm Looks to mRNA Vaccines; Hong Kong…

The latest news from Chinese pharma and biotech, including news that state-owned Sinopharm is now developing its own mRNA vaccine; an update on Hong…

Regulatory Cooperation & Joint Assessments in ASEAN

Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency;…

Rodrigo Rodriguez – General Manager, Middle East Cluster,…

Rodrigo Rodriguez, general manager for Takeda’s Middle East cluster, discusses the company’s ambitions in the collective Saudi pharma market,…

Catherine Williams – Managing Director, MSD Denmark &…

MSD's Catherine Williams, a recent arrival in Copenhagen, gives her first impressions of the Danish healthcare system and pharma market, drawing on…

3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…

The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing…

CEE Pharma News: EU5/CEE Healthcare Disparity; Novavax’s…

The latest pharma news from Central and Eastern Europe (CEE), including a new report on the disparities between the region’s healthcare systems and…

Frederico Silva – General Manager, Gilead Sciences Middle…

Frederico Silva outlines the highlights of his two years heading up Gilead Sciences' relatively young Middle-East affiliate, how Gilead has pivoted to…

Top 5 Pharma R&D Spenders in Europe

The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest and most developed nations are…

Ahmed Alaskar – Executive Director, KAIMRC, Saudi Arabia

Dr Ahmed Alaskar is executive director of the King Abdullah International Medical Research Center (KAIMRC); president of the Saudi Society of Blood…

Tagged with r